Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 1

Status

Completed 4Unknown 3Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Breast 2

Conditions

Motor Activity 2Breast Neoplasms 2Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Wearable Electronic Devices × Clear all
NCT04736576 2024-11-22

JBCRG-26

Pfizer

Phase NA Completed
99 enrolled 47 charts
Breast

Breast Neoplasms, Motor Activity

NCT03773380 2022-03-04

BA

St. Joseph's Healthcare Hamilton

Phase 1 Completed
50 enrolled
Thoracic

Lung Neoplasms

NCT03902834 2019-04-08

Move for Surgery (MFS): Evaluating the Use of Wearable Technology for Preconditioning Before Thoracic Surgery

St. Joseph's Healthcare Hamilton

Phase NA Completed
25 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03072966 2019-01-10

Development of Distress Management Algorithms Using Mobile Device Based Health Logs in Breast Cancer Survivors

Asan Medical Center

Phase NA Completed
160 enrolled
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡